chrisvoncsefalvay/vaers-outcomes huggingface dataset:
bad adverse reactions of the first dose; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (bad adverse reactions of the first dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced ADVERSE REACTION (bad adverse reactions of the first dose). At the time of the report, ADVERSE REACTION (bad adverse reactions of the first dose) outcome was unknown. Not Provided.       The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment information provided.
Blood clot on middle joint of right hand pinky finger. Pressure bandage, heat, Advil. Decreasing in size after 18 days.
Severe migraines, severe dizziness, severe lightheadedness, severe near fainting episodes, increased tachycardia, severe episodes of near fainting accompanying by paleness, severe full body weakness, severe muscle cramps,severe  muscle twitching/jerking, severe chronic fatigue, severe slurring speech, severe studdering, severe trouble with work recall, severe spells of blurry vision, severe nausea, severe feeling of increased pressure in my brain, neck pain, severe increase in urination frequency, severe chest pain, severe palpitations, severe shortness of breathe, pressure/pain/building feeling in left side of neck near/around carotid artery.
Broke out in hives on my upper neck/under chin area shortly after drinking a small glass of wine with my evening meal. (White Zinfandel)  This has never happened before.  The next evening I had another small glass of wine with my meal and the same thing occurred and this time my lower lipped swelled some also.
This spontaneous report was received from a pharmacist regarding a patient of unknown age and gender. Information on the concurrent condition, medical history and pertinent drug allergies of the patient were not reported. On 23-NOV-2015 at time- 12:55, the patient was vaccinated with improperly stored RECOMBIVAX HB lot # L016427 (expiry date, dose #, route, dose units and anatomical location were not specified). Concomitant medication was not reported. No adverse events were reported. The high temperature and low temperature at which the product was stored were 3.3 and 1.9 (units unspecified) respectively. There were no Product Quality Complaint (PQC) involved. This is one of several reports received from same reporter. Additional information has been requested.
Patient stated after having his vaccination on a Friday morning, by the afternoon he started to feel ill. He complained of arm pain, fever and chills that lasted through Saturday until he finally felt better when he woke on the following Sunday morning. He reported that he had to cancel his plans on Saturday and stay home because he felt so bad. He also noted that his sister had a similar reaction and that him and her both had chicken pox as adults.
I started with some unexplained reflux (never before) and abdominal pain, some tmj, teeth grinding during the night.  THEN AFTER THE 3 DOSE I experienced night sweats, and severe teeth grinding, for many days, joint pain, feeling severely tired disturbed sleep and very brained fogged and impaired cognitively: short memory and speech ( couldn't find words). Then after some days I had a severe mouth canker sores breakout. then abdominal pain. Doctors foind very low wbc (2.8) no virus, no bacteria infection was found. I have never had low wbc before.
Client was administered a dose of Hib Pedvax that had recently expired. Expiration date was 7/9/21 and the administration date was 7/20/21. Client's mother, was made aware of the error and was recommended to make a new appointment to vaccinate patient appropriately. Mother did not want to reschedule at this time.
Patient reorted tingling sensation from shoulder down arm and up side of head, on right side. Same side that vaccine was given, right deltoid. Began 7 minutes after vaccination while patient was in the observation area. MD on site and assessed patient. Plan is to monitor for 30 minutes. After 10 more minutes, patient reported tingling in her throat. MD ordered Cetirizine 10mg (Zyrtec) once now. Given to patient at 1255 pm. Vaers info gathered from pateint. 30 min of observation done. Patient feeling well, no swelling nor shortness of breath. MD assess her and discharged her home.
(Pneumonia site only). Patient's arm broke out with hives, severe swelling and redness with inflammation of the area around the vaccination. She  only had a severe local like reaction, which caused her to have to be seen by her primary physician which prescribed her a MEDROL DOSEPAK and KEFLEX. She immediately saw an improvement after taking a few doses of the MEDROL.
on 11/26/21 (8 days following Pfizer Covid booster vaccine) patient had witnessed GTC seizure and was brought to hospital.  Patient underwent MRI brain and EEG which showed T2 hyperintensity and edema in L temporal lobe concerning for HSV encephalitis. Was treated with IV Valacyclovir and returned to baseline within 48 hours.
Sore arm at first and a hard knot, then redness, then warm to the touch, then a rash developed that is itchy.  I am very tired.  I have not had any treatment but have a doctor appointment this week.  It was a week last Friday since I had the vaccine and about a week these symptoms started.
Patient was unable to walk. Left leg did not function properly, could not bear weight. No pain or fever. Symptoms began 1 hour after injection and lasted for 1 hour. Patient recovered.
Patient started experiencing mild itching in the right arm initially and then later reached the back and upper legs starting after 5 minutes post vaccination. The patient received the Janssen COVID vaccine in the left arm, but the itching was only on the right arm. The patient was monitored for an additional 15 minutes for a total of 30 minutes. The severity did not get any worse after 30 minutes. The patient did not have any other reactions. Benadryl was recommended to the patient for itch relief. The pharmacy followed up with the patient after she went home and her condition did not get any worse. She plans to use some anti-itch remedies for the itching.
PATIENT RECIEVED VACCINE VIA STANDARD PROTOCOLS/INJECTION TECHNIQUE. PT PREPARED TO LEAVE AND PRESENTED TO PHARMACY COUNTER STATING DIZZINESS.  RPH ASSISTED PT TO SEATED POSITION AND PT STATED HE WAS "FEELING BETTER". PT APPEARED AS THOUGH HE WAS GOING TO FAINT SO RPH ASSISTED IN LOWERING HIM TO THE GROUND TO A SUPINE POSITION AND ELEVATED HIS FEET. PT CONTINUED TO BE RESPONSIVE BUT AT ONE POINT ASKED IF HE "PASSED OUT".  PATIENT REPORTED FEELING HOT AND RINGING EARS. WHEN PATIENT FELT BETTER, RPH ASSISTED HIM TO A SEATED POSITION AND GAVE HIM AN ORANGE JUICE. WHEN PT FELT ABLE, RPH ASSITED HIM TO SIT IN A CHAIR. PT REMAINED IN PHARMACY FOR 15 MINUTES FOR OBSERVATION. PT STATED NO ADDITIONAL SYMPTOMS OR CONCERNS AND WAS RELEASED.
Left arm very swollen, covering small portion of breast; Left arm very swollen, covering small portion of breast; This is a spontaneous report from a contactable consumer, the patient. A 67-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 09Mar2021 at 18:15 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. Medical history included type 2 diabetes, osteoarthritis, gastroesophageal reflux disease (GERD) and known allergy to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included vitamins (MANUFACTURER UNKNOWN) and unspecified medications for diabetes, heart and cholesterol; all from unknown dates and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Mar2021, the patient experienced left arm very swollen, covering small portion of breast that lasted 5-6 days. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events left arm very swollen, covering small portion of breast was resolved on an unknown date in Mar2021.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Pt recv vax on 10/21/98; on 10/22/98 pt exp fever (104F), lump/red vax site-LA, swelling in throat & axillary lymph node; tx=Prednisone, Benadryl, ice
Local injection reaction swelling soreness (vaccine given IM) redness, swelling to about 1/2 egg, hot/flush, painful happened about 1 day after and lasting to 1 week after. Possible IM tear. Lasted for over 1 week.
Information has been received from a physician concerning a 21 year old female patient who on unspecified date received three doses of GARDASIL (Lot# not reported), IM. The physician stated that the patient experienced test results that determined the woman to be in high risk for Human Papillomavirus (HPV) with mild dysplasia after being administered GARDASIL. At the time of the report the patient's outcome was unknown. The patient did not seek medical attention. This is one from several reports received from the same source. Additional information has been requested.
Dizzy light headed sore and itchy eyes really red headache and fatigue I layed down in bed and trayed to relax and weight for the symptoms to go away I took ibuprofen for the aches and pain.
I started having symptoms of COVID-19 on December 13, 2022. I called my doctor and requested a COVID-19 test. I took a PCR COVID-19 test on December 14, 2022. I requested a prescription for PAXLOVID. I started PAXLOVID that evening. My symptoms initially included fever, chills, body aches, and joint pain. Those symptoms resolved by Friday, December 16, 2022. I also had head cold symptoms that included congestion, cough, and runny nose. Those continued for two weeks. I still feel fatigued. I've experienced heart palpitations, and those have continued as well. I saw a cardiologist on January 4, 2023. The cardiologist noted changes in my condition from a year ago including bradycardia and hypertension.
PAINFUL LARGER RASH UNDER INJECTION SITE PER PATIENT.  PATIENT STATED VERY PAINFUL AND SLIGHTLY INFLAMMED AND WARM TO TOUCH.  PATIENT STATES RASH IS ABOUT 1 INCH UNDER WHERE INJECTION WAS GIVEN, I COULD NOT TELL WHERE INJECTION WAS GIVEN TODAY.   THIS PATIENT HAD TO GET REVACCINATED ON 7/24/20 DUE TO SYRINGE HUB FAILING AND MOST OF VACCINE CAME OUT AT HUB AND RAN DOWN ARM.
Palpitations, Tachycardia lasting more than 12 hours, occasional PVCs, Bradycardia, fainting, shortness of breath, chest pain.
pt recv vax & exp an elevated PTT & PT;an ER or MD visit was required;pt was found to have a factor eight inhibitor;sc have not subsided;
Patient developed a large (approximately 5" diameter) rash, and severe flu-like symptoms - she said could barely get out of bed the next day.
pt recvd vax 20APR94 & 21APR94 pt t100 & by 22APR93 temp was back to nl; 27APR t104.6 & pt had 2 seizures; pt was seen in ER & had a neg CXR; a neg strep cult, a WBC of 15,561; BC was done that revealed pneumococcus;
Day after vaccination, 2 red areas - painful areas under (R) & (L) breast areas more so on right side saw MD, diagnosed as cellulitis, possibly triggered by vaccine.
Friend got a booster dose of Moderna after a primary series of Moderna. Full dose; No adverse event; This spontaneous case was reported by a consumer and describes the occurrence of ACCIDENTAL OVERDOSE (Friend got a booster dose of Moderna after a primary series of Moderna. Full dose) and NO ADVERSE EVENT (No adverse event) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ACCIDENTAL OVERDOSE (Friend got a booster dose of Moderna after a primary series of Moderna. Full dose) and NO ADVERSE EVENT (No adverse event). At the time of the report, ACCIDENTAL OVERDOSE (Friend got a booster dose of Moderna after a primary series of Moderna. Full dose) and NO ADVERSE EVENT (No adverse event) outcome was unknown.            No concomitant medication provided. No treatment information mentioned.  Reporters friend took the booster dose of Moderna after primary series of Moderna, but took a full dose.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in
This is a spontaneous report from a contactable pharmacist. A 69-year-old female patient received a single dose of PREVNAR13; Lot Number: H86680; Expiration Date: OCT2015), intramuscularly in the deltoid muscle of the arm on 09DEC2014 at 1:00 PM, which was administered by the pharmacist. No vaccine was given on the same day; however other unspecified vaccines were given four weeks prior to the day of administration with PREVNAR13. The patient's medical history and concomitant medications were not reported. On the morning of 10DEC2014, the patient experienced weakness and sickness. The patient did not require an emergency room visit or doctor visit. The reporting pharmacist dd not know about the blood and laboratory test for the patient. The clinical outcome for the events of weakness and sickness was unknown. The causality was assessed by the reporting pharmacist who believed the events of weakness and sickness was due to the vaccine. The pharmacist did not know how the patient purchased the vaccine. The pharmacist did not want the physician to be contacted. Follow-up (11FEB2015): Follow-up attempts completed. No further information expected.
Itchy, red, blotchy rash that started most likely 3 days after the vaccination. Pt was scratching it and then the next day realized there is a large rash at the site of injection. She presented the pharmacy with a large (4in) blotchy, red rash, hot to the touch.
Rebound- tested positive 04Jul after negative on 29Jun. Mild or no symptoms; Rebound- tested positive 04Jul after negative on 29Jun. Mild or no symptoms; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 62-year-old male patient received BNT162b2 (BNT162B2), on 20Feb2021 at 10:00 as dose 1, single (Lot number: EN6198), in right arm, as dose 2 , single (Lot number: EN6204), in right arm, on 28Sep2021 at 14:00 as dose 3 (booster), single (Lot number: FF2588), in right arm and on 29Mar2022 at 16:00 as dose 4 (booster), single (Lot number: FR9813) at the age of 62 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "high blood pressure" (unspecified if ongoing); "overweight" (unspecified if ongoing); "high cholesterol" (unspecified if ongoing). There were no concomitant medications. Past drug history included: Phenergan, reaction(s): "Known allergies: phenergan". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 04Jul2022 at 21:00, outcome "recovering" and all described as "Rebound- tested positive 04Jul after negative on 29Jun. Mild or no symptoms". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (29Jun2022) Negative, notes: Rebound- tested positive 04Jul after negative on 29Jun; (04Jul2022) Positive, notes: Rebound- tested positive 04Jul after negative on 29Jun. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Addition information: Start date of treatment for COVID-19 was 22Jun2022. Stop date of treatment for COVID-19 was 26Jun2022.
This spontaneous report as received from a registered nurse refers to unspecified number of patient of unknown age and gender. Approximately on an unknown date in September 2013, the patients may might have been vaccinated with a dose of MMR II (lot number, expiry date, route and dose were not reported) exposed to 55 Fahrenheit for as much time as 5 hours. No additional information was currently available at this time and there was no adverse experience to report. Additional information has been requested.
Information has been received from a physician concerning a 26 year old female with no medical history or no known drug allergies, who on 02-JAN-2008 was vaccinated IM with a first dose of GARDASIL vaccine (yeast) (Lot# 660393/0067X). Concomitant therapy included ACETEXA. On 07-Jul-2008 the patient received the second dose of GARDASIL vaccine (yeast). Within a few hours of vaccination the patient experienced redness, pain and swelling at the injection site. The patient also mentioned after she received the second dose, that she did have a similar reaction after the first dose. Medical attention was not sought. On an unspecified date the patient was recovered. Additional information has been requested.
Joint pain in left elbow, right wrist and knuckles of right hand.  The pain is ongoing and scepter for the wrist pain.
She wasn't feeling well; This is a spontaneous report from a contactable consumer or other non hcp.  A 60-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EW0158 and Expiry date: Unknown) dose 1 via an unspecified route of administration, administered in Arm Left on 10Apr2021 as 1st dose, single dose (at the age of 60-year-old) for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient had no prior vaccinations within last 4 weeks. The patient experienced she wasn't feeling well on Apr2021. The caller stated she received her first shot 10Apr2021 and she was supposed to get the second shot 3 weeks later but she was not feeling well. She was afraid to get it. She went to the place and they told her she probably should not get it. She wasn't feeling well and so she postponed it. She got the shot on 27May2021and that is 6 weeks later. The outcome of event was unknown.
GOT COVID; This spontaneous report received from a patient via social media via a company representative concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company was unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced got covid. Laboratory data (dates unspecified) included: COVID-19 virus test (NR: not provided) Positive. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of got covid was not reported. This report was non-serious. This report was associated with product quality complaint: 90000209424.; Sender's Comments: V0; Medical assessment comment not required as per standard procedure as case assessed as non-serious.
Severely sore throat; congestion in throat; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 74-year-old male patient received bnt162b2 (BNT162B2), administration date 04Mar2021 (Lot number: EN6199) at the age of 74 years as dose 2, single and administered in arm left, administration date 26May2021 (Lot number: ER2613) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Lymphoma" (unspecified if ongoing); "Known allergies:Penicillin" (unspecified if ongoing). Concomitant medication(s) included: LYRICA; TYLENOL. The following information was reported: OROPHARYNGEAL PAIN (non-serious) with onset 07Mar2021, outcome "not recovered", described as "Severely sore throat"; RESPIRATORY TRACT CONGESTION (non-serious) with onset 07Mar2021, outcome "not recovered", described as "congestion in throat". The events "severely sore throat" and "congestion in throat" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of oropharyngeal pain, respiratory tract congestion.  Follow-up attempts are completed. No further information is expected.
patient states about 2 weeks after receiving  vaccine, her armpit and underside of upper arm started swelling.  Swelling migrated to left side of face, under left breast and left leg.  She saw her PCP today and he stated it was from the Moderna Bivalent vaccine and to rest her left arm, use a heating pad and take something to help her sleep at night.  She has been very uncomfortable since the swelling started and is concerned this is from the Moderna vaccine she received on 9/21/22.  Her initial side effects after injection were injection side pain that went away in a couple days.
I started having pain and tingling on the soles my feet toes that has progressed up to my ankles and shins. I am now also experiencing numbness in my feet and toes. I have been referred to a podiatrist, who then referred me to a pain management/podiatrist who ran nerve conduction study. They have referred me to another podiatrist to see if they can discover what is causing my numbness, pain and tingling in my feet and toes.
The lungs did not bring up much phlegm's like before; Breathing problems improved like after receiving the steroid shot; This spontaneous case was reported by a patient and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (The lungs did not bring up much phlegm's like before) and PRE-EXISTING CONDITION IMPROVED (Breathing problems improved like after receiving the steroid shot) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021B21A and 027A21A) for COVID-19 vaccination.     Concurrent medical conditions included Bronchitis (Underlying lungs problem) since January 2020.   On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (The lungs did not bring up much phlegm's like before) and PRE-EXISTING CONDITION IMPROVED (Breathing problems improved like after receiving the steroid shot). At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (The lungs did not bring up much phlegm's like before) and PRE-EXISTING CONDITION IMPROVED (Breathing problems improved like after receiving the steroid shot) outcome was unknown.            Concomitant medicines include Inhalers for Bronchitis Patient wants to Thank each and everyone of Moderna team member's for the wonderful job Action taken with mRNA-1273 in response to the event was not applicable
Weird feeling no my left neck. Stiff? Like something is pulling on it.  The nurse practioner told me to wait a month, but it has not completely gone away yet.